A randomized clinical trial for the effects of halothane and isoflurane anesthesia on blood glucose levels in the diabetic patients

Daru

Volumn 17, Issue 1, 2009, Pages 29-32

  Farrokhnia, F ^a   Lebaschi, A H ^b   Andalib, N ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NONE   (Iran)

Author keywords

Anesthesia; Diabetes; Halothane; Isoflurane

Indexed keywords

HALOTHANE; ISOFLURANE;

ADULT; ANESTHESIA INDUCTION; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC PATIENT; DRUG CYTOTOXICITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OPERATION DURATION; POSTANESTHESIA CARE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; RANDOMIZED CONTROLLED TRIAL; RECOVERY ROOM; SURGICAL PATIENT;

EID: 62649120468     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Gardner SG, Bingley PJ, Sawtell PA, Weeks 5, Gale EAM. Rising incidence of insulin dependent diabetes in children aged under 5 years in the Oxford region: time trend analysis. Br Med J 1997; 315: 713-17.
2. King H, Rewers M. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care 1993; 16: 157-77.
3. Ruwaard D, Hirasing RA, Reeser HM et al. Increasing incidence of type I diabetes in The Netherlands. The second nationwide study among children under 20 years of age. Diabetes Care 1994; 17: 599-601.
4. DECODE Study Group, on behalf of the European Diabetes Epidemiology Study Group. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. Br MedJ 1998; 3 17:371-5.
5. Hikasa Y, Yoshikai T, Takase K, Ogasawara S. Comparisons of prolonged sevoflurane, isoflurane, and halothane anaesthesia combined with nitrous oxide in spontaneously breathing cats. Zentralbl Veterinarmed A. 1997 Sep;44(7):427-42.
6. st ed. London: Chapman and Hall; 1991.
7. McAnulty GR, Robertshaw HJ, Halll GM. Anaesthetic management of patients with diabetes mellitus. Br J Anaesth 2000; 85: 80-90.
8. Gingerich R, Wright PH, Paradise RR. Inhibition by halothane of glucose-stimulated insulin secretion in isolated pieces of rat pancreas. Anesthesiology 1974; 40: 449-52.
9. Aynsley-Green A, Biebuyck JF, Alberti KG. Anaesthesia and insulin secretion: the effects of diethyl ether, halothane, pentobarbitone sodium and ketamine hydrochloride on intravenous glucose tolerance and insulin secretion in the rat. Diabetologia. 1973 Aug;9(4):274-81.
10. Gingerich R, Wright PH, Paradise RR. Effects of halothane on glucose-stimulated insulin secretion and glucose oxidation in isolated rat pancreatic islets. Anesthesiology. 1980 Sep;53(3):219-22.
11. Desborough JP, Jones PM, Persaud SJ, Landon MJ, Howell SL. Isoflurane inhibits insulin secretion from isolated rat pancreatic islets of Langerhans. Br J Anaesth. 1993 Dec;71(6):873-6.
12. Laber-Laird K, Smith A, Swindle MM, Colwell J. Effects of isoflurane anesthesia on glucose tolerance and insulin secretion in Yucatan minipigs. Lab Anim Sci. 1992 Dec;42(6):579-81.
13. Desborough JP, Knowles MG, Hall GM. Effects of isoflurane-nitrous oxide anaesthesia on insulin secretion in female patients. Br J Anaesth. 1998 Feb;80(2):250-2.
14. Diltoer M, Camu F. Glucose homeostasis and insulin secretion during isoflurane anesthesia in humans. Anesthesiology. 1988 Jun;68(6):880-6.
15. Tanaka T, Nabatame H, Tanifuji Y. Insulin secretion and glucose utilization are impaired under general anesthesia with sevoflurane as well as isoflurane in a concentration-independent manner. J Anesth. 2005;19(4):277-81.